Loading...

Insulet Corporation

PODDNASDAQ
HealthcareMedical - Devices
$311.77
$-5.39(-1.70%)

Insulet Corporation PODD Peers

See (PODD) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
PODD$311.77-1.70%21.9B56.07$5.56N/A
ABT$133.55-0.29%232.4B17.34$7.70+1.71%
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
BSX$102.04-0.77%151B74.48$1.37N/A
SYK$384.07+0.25%146.8B51.97$7.39+0.85%
MDT$87.38+0.44%112.1B24.20$3.61+3.21%
EW$77.52-0.32%45.5B32.03$2.42N/A
DXCM$86.67+1.08%34B65.17$1.33N/A
STE$243.73+0.06%24B39.63$6.15+0.92%
PHG$23.46+0.56%21.7B78.20$0.30+3.77%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

PODD vs ABT Comparison

PODD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PODD stands at 21.9B. In comparison, ABT has a market cap of 232.4B. Regarding current trading prices, PODD is priced at $311.77, while ABT trades at $133.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PODD currently has a P/E ratio of 56.07, whereas ABT's P/E ratio is 17.34. In terms of profitability, PODD's ROE is +0.35%, compared to ABT's ROE of +0.31%. Regarding short-term risk, PODD is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for PODD.

Stock Price Comparison

Loading...

Frequently Asked Questions